FDA drops plan to regulate fecal transplant procedures

06/19/2013 | National Public Radio

The FDA will no longer require regulatory approval for doctors to perform fecal transplants, provided the procedure is used only in patients with Clostridium difficile who have failed to respond to other treatments. In a statement, the FDA said it will "exercise enforcement discretion" and devise "appropriate policies for the study and use" of the procedure.

View Full Article in:

National Public Radio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI